logo

Cabaletta Bio, Inc. (CABA)



Trade CABA now with
  Date
  Headline
7/7/2020 8:21:43 AM Cabaletta Bio, Artisan Bio Announce Gene Editing Research And Collaboration Agreement
5/6/2020 8:04:47 AM Cabaletta Bio Gets FDA Fast Track Designation For DSG3-CAART For Treatment Of Mucosal Pemphigus Vulgaris
1/29/2020 8:11:56 AM Cabaletta Bio: FDA Grants DSG3-CAART Orphan Drug Designation For Pemphigus Vulgaris